Physician profile
Kenneth Lu
NPI 1467514265
$16,671.38
in general payments reported to CMS, 2019-2025
26 companies · $2,653 in 2025
The $2,653 reported for 2025 was more than what 91% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,089 · 2020: $830 · 2021: $2,354 · 2022: $3,056 · 2023: $3,609 · 2024: $2,081 · 2025: $2,653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,342.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $8,331.93 | 2019-2025 | Ngenuity, Clareon, Hydrus Microstent |
| Bausch & Lomb Americas INC. | $2,095.58 | 2022-2024 | Envista Mx60 Iol, Amvisc, Xiidra |
| Sight Sciences, INC. | $1,112.60 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| Johnson & Johnson Surgical Vision, INC. | $842.79 | 2019-2025 | Tecnis Simplicity, Tecnis Iol, Tecnis Iol |
| Beaver-Visitec International, INC. | $782.87 | 2021-2023 | |
| Ocular Therapeutix, INC. | $648.00 | 2020-2025 | Dextenza |
| Novartis Pharmaceuticals Corporation | $437.71 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $397.52 | 2019-2020 | |
| Glaukos Corporation | $371.45 | 2019-2022 | |
| Shire North American Group INC | $244.73 | 2019 | |
| Carl Zeiss Meditec, INC. | $241.88 | 2019 | |
| Sun Pharmaceutical Industries INC. | $184.42 | 2019 | |
| Medtronic, INC. | $155.99 | 2022 | |
| Ivantis, INC | $154.08 | 2020 | |
| Nova Eye, INC. | $151.33 | 2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $133.38 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd) |
| Amgen INC. | $124.98 | 2024 | Krystexxa |
| Allergan, INC. | $124.95 | 2021 | |
| Topcon Healthcare Solutions, INC. | $35.76 | 2019 | |
| Merz Pharmaceuticals, LLC | $25.05 | 2025 | Xeomin |
| Harrow Eye, LLC | $19.49 | 2024 | Iheezo |
| Eyepoint US, INC. | $14.55 | 2021 | |
| Eyevance Pharmaceuticals LLC | $13.82 | 2022 | |
| Lumibird Medical INC. | $13.48 | 2025 | |
| Horizon Therapeutics Plc | $13.04 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.